Table 1.
Cell Type/Tissue | Effects of NS8593 | References |
---|---|---|
HEK293, | Motility/chemotaxis | [101] |
primary microglia, | [110] | |
A172 glioblastoma cells | [111] | |
Primary ventricular myocytes, | Mg2+ homeostasis | [112,113] |
primary vascular smooth muscle cells, | [114] | |
HT29 epithelial colon cells | [115] | |
Mouse oocytes and eggs, | Ca2+ uptake, intracellular Ca2+ stores and Ca2+ signalling | [41,116] |
DT40 B lymphocytes, | [117] | |
primary enamel cells, | [118] | |
3T3-L1 fat cells | [119] | |
MDA-MB-231 breast cancer cells, | Proliferation/cell cycle | [120] |
A172 glioblastoma cells | [111] | |
MDA-MB-468 breast cancer cells | Differentiation | [121] |
Primary B cells, | Immune responses | [122] |
mouse erythrocytes | [123] | |
primary microglia | [120] | |
primary macrophages | [110] | |
HuH7 hepatocellular carcinoma in a xenograft mouse model | Tumour growth | [74] |
Kidneys | Fibrosis | [49] |